Apteranthes europaea
Apteranthes europaea · Accepted scientific name
Scientific literature: Very Sparse (13 studies) · ★☆☆☆☆
Apteranthes europaea is a plant species that has garnered significant scientific interest due to its diverse pharmacological activities. Research indicates that its various preparations, such as methanolic and hydroethanolic extracts, exhibit potent anticancer, antidiabetic, and antioxidant properties. The therapeutic potential of the plant is largely attributed to key chemical constituents, including ferulic acid, hesperetin, 3,4-dihydroxybenzoic acid, and benzofurazan. Beyond these roles, the plant demonstrates beneficial effects against various conditions, serving as an antiparasitic and antipyretic agent. Consequently, studying these specific extracts provides valuable insights into the plant's complex medicinal profile.
- Synonyms
- Desmidorchis Europaea · Ceropegia Europaea · 3 more
- Common names
- Not available
- Family
- Apocynaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Synonyms
Apteranthes europaea is a botanical subject characterized by a complex history of taxonomic classifications. Due to various scientific reevaluations, this species is frequently documented under several different names. It is recognized by synonyms such as Boucerosia europaea and Caralluma europaea in various botanical records. Furthermore, the plant has been historically linked to names like Ceropegia europaea and Desmidorchis europaea. Researchers also encounter it listed as Stapelia europaea, highlighting the shifting nomenclature associated with this organism.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Apteranthes europaea is a distinctive botanical specimen that belongs to the kingdom Plantae. Within this vast biological realm, the species is classified under the class Equisetopsida. It is further categorized into the order Gentianales, which defines its specific evolutionary lineage. As a member of the family Apocynaceae, it shares structural traits with many other specialized flowering plants. Ultimately, this plant is defined by its unique placement within the genus Apteranthes.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Gentianales |
| Family | Apocynaceae |
| Genus | Apteranthes |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Apteranthes europaea is a plant species primarily found throughout the diverse landscapes of Northern Africa. Its distribution is concentrated within several key countries, including Algeria and Egypt. The species also maintains a notable presence across the territories of Libya and Morocco. Furthermore, its range extends into the coastal and inland regions of Tunisia. This specific geographic pattern highlights the plant's strong affinity for the North African climate.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Apteranthes europaea develops into a robust shrubby growth form. This plant is naturally self-supporting, allowing it to maintain its structure within its environment.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Apteranthes europaea, also known as Caralluma europaea, is a medicinal plant traditionally valued in Moroccan folk medicine for its diverse therapeutic properties. Research has demonstrated that its extracts possess significant anticancer activity, specifically showing effectiveness against colorectal, prostate, and pancreatic cancer cell lines. The plant also exhibits notable antidiabetic potential by helping to regulate blood glucose levels and protecting pancreatic tissue. Additionally, studies have confirmed its antinociceptive effects for pain management, as well as its antioxidant and antiparasitic capabilities. These multifaceted biological activities suggest that the plant's bioactive compounds could serve as a promising foundation for developing new natural therapeutic agents.
Compounds
Apteranthes europaea, also known as Caralluma europaea, is a medicinal plant rich in various bioactive phenolic compounds. Detailed chemical analyses have revealed that the plant contains ferulic acid, which serves as its primary phenolic constituent. Additionally, the presence of quercetin provides significant antioxidant properties to its extracts. Other important secondary metabolites identified within the plant include benzofurazan and the antioxidant polyphenols catechin and epigallocatechin. These diverse chemical relationships underscore the plant's potential therapeutic value in managing conditions such as diabetes and cancer.
Conditions
Apteranthes europaea, also known as Caralluma europaea, demonstrates significant anticancer effects through its ability to induce apoptosis and cell cycle arrest. The plant's methanolic extracts specifically exert antiproliferative activities against the DU145 prostate cancer cell line and the HCT116 colorectal cancer cell line. Beyond its antitumoral potential, the species possesses notable antidiabetic properties by inhibiting α-glucosidase activity and reducing postprandial hyperglycemia. Additionally, the plant is recognized for its antinociceptive effects, which contribute to its traditional use in medicinal remedies. These diverse therapeutic actions highlight the plant's potential as a source for developing effective natural bioactive agents.
Preparations
Apteranthes europaea is prepared as methanolic extract to investigate its antidiabetic and antiproliferative properties. This plant is also prepared as methanol extract for studies focusing on its antioxidant effects and blood glucose regulation in diabetic mice. Research further utilizes Apteranthes europaea prepared as extracts to evaluate its broad medicinal potential, including wound healing and antinociceptive activities. Additionally, the species is prepared as hydroethanolic extract to explore its chemical composition and hepatoprotective capabilities. Finally, the plant is prepared as hydroethanolic to facilitate the analysis of its bioactive compound classes and antioxidant power.